Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Which therapies is lurbinectedin combined with?

See the DrugPatentWatch profile for lurbinectedin

What combinations are already being tested with lurbinectedin?

Clinical trials combine lurbinectedin with doxorubicin for soft tissue sarcomas. [1] The same pair is also tested in ovarian cancer, ovarian, ovarian, ovarian, ovarian, ovarian, ovarian, and ovarian. The pair is tested in ovarian cancer. [2] Lurbinectedin plus irinotecan is under evaluation in neuroendocrine tumors. [3] Lurbinectedin and atezolizumab are tested together for small cell lung cancer. [1]

When does patent expire?

Patent expires December 2027. [4]

Can biosimilars enter before patent expiry?

No.

When does exclusivity expire?

Exclusivity expires May 2025. [4]

What side effects are patients asking about?

Patients report bone marrow suppression, fatigue, and nausea. [1]

Who makes lurbinectedin?

Zentiva, and also Pharma Mar. [4]

Source: [1] ClinicalTrials.gov

Source: [2] ClinicalTrials.gov

Source: [3] ClinicalTrials.gov

Source: [2] ClinicalTrials.gov

Source: [4] DrugPatentWatch.com



Other Questions About Lurbinectedin :

How does acupuncture's mechanism help lurbinectedin induced nausea? Are there any known contraindications for lurbinectedin? Which organs need monitoring with lurbinectedin use? How can oncologists manage lurbinectedin's delayed adverse effects? What role does lurbinectedin play in extending patient survival? Lurbinectedin side effects? What is the suggested assessment frequency for lurbinectedin side effects?